Rapid Nutrition's Expanding Market Performance Enables Cash Repayment to Reduce Convertible Loans
London, United Kingdom, August 27, 2024 – Rapid Nutrition PLC (Euronext Growth: ALRPD), specialising in health and wellness products, is pleased to announce that management has decided to repay a portion of its upcoming Atlas funding instalment in cash. This strategic move is aimed at minimizing potential dilution for shareholders, reinforcing the company’s commitment to protecting shareholder value as it continues to achieve significant progress in key markets such as China and Australia.
This partial cash repayment, scheduled for this month, is a direct result of the company's financial performance and cash reserves, particularly driven by the success of its strategic initiatives in China and Australia. By choosing to repay part of the instalment in cash, Rapid Nutrition is taking a proactive approach to preserve equity value for its shareholders.
Simon St. Ledger, CEO of Rapid Nutrition, stated: “Our decision to repay a portion of the Atlas instalment in cash reflects our dedication to safeguarding shareholder interests by reducing potential dilution. The strong progress we’ve made in China and Australia has not only strengthened our financial position but also provided us with the flexibility to make decisions that align with our long-term growth strategy and shareholder value creation.”
This decision aligns with Rapid Nutrition’s broader financial strategy of maintaining a healthy balance sheet while strategically minimizing equity dilution. The company’s recent successes in the Chinese market, coupled with solid performance in other key markets have significantly contributed to its financial stability, allowing for this prudent repayment decision.
Rapid Nutrition’s ongoing growth in these key markets positions the company well for future opportunities while managing its financial obligations in a way that prioritizes shareholder value.
For more information about Rapid Nutrition PLC and its product offerings, including market insights, please visit www.rnplc.com.
About Rapid Nutrition
Rapid Nutrition is a leading health and wellness company committed to providing innovative solutions for a healthier world. With a focus on research-backed formulas, we empower individuals to optimize their well-being and face life's challenges with confidence.
Investor Relations Contact:
Disclaimer
This press release contains forward-looking statements made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995 and or otherwise that involve risks, uncertainties and assumptions that could cause Rapid Nutrition PLCs actual results and experience to differ materially from anticipated results and expectations expressed in these forward-looking statements. Rapid Nutrition PLC has in some cases identified forward-looking statements by using words such as "anticipates," "believes," "hopes," "estimates," "looks," "expects," "plans," "intends," "goal," "potential," "may," "suggest," and similar expressions. Rapid Nutrition PLC undertakes no obligation to release publicly the results of any revisions to any such forward-looking statements that may be made to reflect events or circumstances after the date of this press release or to reflect the occurrence of unanticipated events, except as required by applicable law or regulation.
This media information does not constitute an offer to sell, or a solicitation of an offer to buy, any securities. This information does not constitute an offering prospectus within the meaning within the meaning of Regulation (EU) 2017/1129 of the European Parliament and of the Council of 14 of June 2017 on the prospectus to be published when securities are offered to the public or admitted to trading on a regulated market, and repealing Directive 2003/71 or a listing prospectus within the meaning of the listing rules of the Euronext Exchange or OTC Markets. The media release is in accordance with International Reporting Standard: Rule 12g3-2(b) under the Securities Exchange Act ('Rule 12g3-2(b)') permits non-U.S. companies with securities listed primarily on a Qualified Foreign Exchange to make publicly available to U.S investors in English the same information that is made publicly available in their home countries as an alternative to SEC reporting Exchange Act Rule 12g3-2(b).